SG Americas Securities’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

SG Americas Securities’s Portfolio NWBO Stock Details NWBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-36,072	Closed	-$53K	–	3335
2016 Q1	$53K	Buy	+36,072	New	+$71.2K	﹤0.01%	2757
2014 Q3	–	Sell	-56,652	Closed	-$380K	–	3049
2014 Q2	$380K	Buy	56,652 +42,852	+311%	+$273K	﹤0.01%	1788
2014 Q1	$100K	Buy	+13,800	New	+$81.8K	﹤0.01%	2223

Other funds holding NWBO

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

SG Americas Securities's NWBO Position: Q2 2016 in Review

SG Americas Securities sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q2 2016, closing a stake of 36,072 shares — an estimated $53K sold.

SG Americas Securities first reported a position in NWBO in Q1 2014 and held it in 3 quarters. The position peaked at $380K in Q2 2014. 64 funds tracked by Wall St. Rank hold NWBO as of Q2 2016.

SG Americas Securities reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q2 2016 after selling out during the quarter.
SG Americas Securities sold 36,072 Northwest Biotherapeutics, Inc. Common stock shares in Q2 2016, an estimated $53K.
SG Americas Securities first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q1 2014 and held it in 3 quarters.
SG Americas Securities's Northwest Biotherapeutics, Inc. Common stock position peaked at $380K in Q2 2014.
64 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q2 2016.

Based on SG Americas Securities's 13F filing for Q2 2016, filed 3 Aug 2016.